The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirunpetcharat, C.
Right arrow Articles by Good, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirunpetcharat, C.
Right arrow Articles by Good, M. F.

The Journal of Immunology, Vol 159, Issue 7 3400-3411, Copyright © 1997 by American Association of Immunologists

ARTICLES

Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells

C Hirunpetcharat, JH Tian, DC Kaslow, N van Rooijen, S Kumar, JA Berzofsky, LH Miller and MF Good
Queensland Institute of Medical Research, Brisbane, Australia.

The 19-kDa carboxyl-terminal fragment of the merozoite surface protein- 1 (MSP1) is a leading malaria vaccine candidate but is unable to induce immunity in all monkeys or all strains of mice. The mechanism of immunity is unclear, although data show that cell-mediated immunity plays a critical role following immunization with the larger mature MSP1 protein. We optimized a vaccine protocol using the MSP1(19) fragment of Plasmodium yoelii expressed in Saccharomyces cerevisiae, such that following exposure of mice to parasites, they remained undetectable in peripheral blood, whereas control animals all died at very high parasitemia within 10 days. We then depleted the vaccinated mice of >99% of CD4+ T cells by anti-CD4 mAb treatment and could show that infections in most animals remained subpatent following challenge. Furthermore, mice in which the gene for the mu-chain of Ig had been disrupted could not be immunized with MSP1(19). Immunity in normal mice did not depend on the presence of an intact spleen nor production of nitric oxide, persisting unabated when >70% of splenic macrophages were depleted. Thus, while effector CD4+ T cells may contribute to immunity, neither they nor factors associated with a Th1-type cell mediated immune response appeared to play the major role in MSP1(19)-induced protection in normal mice. Furthermore, T cells were not sufficient for immunity in mice lacking B cells. In normal mice, protection correlated with a very high titer of MSP1(19)-specific Abs (>6,400,000), predominantly G1 and G2b, which may function by merozoite neutralization.


This article has been cited by other articles:


Home page
 CVIHome page
S. A. Kaba, A. Price, Z. Zhou, V. Sundaram, P. Schnake, I. F. Goldman, A. A. Lal, V. Udhayakumar, and C. W. Todd
Immune Responses of Mice with Different Genetic Backgrounds to Improved Multiepitope, Multitarget Malaria Vaccine Candidate Antigen FALVAC-1A
Clin. Vaccine Immunol., November 1, 2008; 15(11): 1674 - 1683.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. A. Ogun, L. Dumon-Seignovert, J.-B. Marchand, A. A. Holder, and F. Hill
The Oligomerization Domain of C4-Binding Protein (C4bp) Acts as an Adjuvant, and the Fusion Protein Comprised of the 19-Kilodalton Merozoite Surface Protein 1 Fused with the Murine C4bp Domain Protects Mice against Malaria
Infect. Immun., August 1, 2008; 76(8): 3817 - 3823.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
B. W. Faber, E. J. Remarque, W. D. Morgan, C. H. M. Kocken, A. A. Holder, and A. W. Thomas
Malaria Vaccine-Related Benefits of a Single Protein Comprising Plasmodium falciparum Apical Membrane Antigen 1 Domains I and II Fused to a Modified Form of the 19-Kilodalton C-Terminal Fragment of Merozoite Surface Protein 1
Infect. Immun., December 1, 2007; 75(12): 5947 - 5955.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
P. Jeamwattanalert, Y. Mahakunkijcharoen, L. Kittigul, P. Mahannop, S. Pichyangkul, and C. Hirunpetcharat
Long-Lasting Protective Immune Response to the 19-Kilodalton Carboxy-Terminal Fragment of Plasmodium yoelii Merozoite Surface Protein 1 in Mice
Clin. Vaccine Immunol., April 1, 2007; 14(4): 342 - 347.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
Q. Shi, M. M. Lynch, M. Romero, and J. M. Burns Jr.
Enhanced Protection against Malaria by a Chimeric Merozoite Surface Protein Vaccine
Infect. Immun., March 1, 2007; 75(3): 1349 - 1358.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
D. L. Narum, S. A. Ogun, A. H. Batchelor, and A. A. Holder
Passive Immunization with a Multicomponent Vaccine against Conserved Domains of Apical Membrane Antigen 1 and 235-Kilodalton Rhoptry Proteins Protects Mice against Plasmodium yoelii Blood-Stage Challenge Infection.
Infect. Immun., October 1, 2006; 74(10): 5529 - 5536.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. Singh, K. Miura, H. Zhou, O. Muratova, B. Keegan, A. Miles, L. B. Martin, A. J. Saul, L. H. Miller, and C. A. Long
Immunity to Recombinant Plasmodium falciparum Merozoite Surface Protein 1 (MSP1): Protection in Aotus nancymai Monkeys Strongly Correlates with Anti-MSP1 Antibody Titer and In Vitro Parasite-Inhibitory Activity.
Infect. Immun., August 1, 2006; 74(8): 4573 - 4580.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
U. Woehlbier, C. Epp, C. W. Kauth, R. Lutz, C. A. Long, B. Coulibaly, B. Kouyate, M. Arevalo-Herrera, S. Herrera, and H. Bujard
Analysis of Antibodies Directed against Merozoite Surface Protein 1 of the Human Malaria Parasite Plasmodium falciparum
Infect. Immun., February 1, 2006; 74(2): 1313 - 1322.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
Q. Shi, A. Cernetich, T. M. Daly, G. Galvan, A. B. Vaidya, L. W. Bergman, and J. M. Burns Jr
Alteration in Host Cell Tropism Limits the Efficacy of Immunization with a Surface Protein of Malaria Merozoites
Infect. Immun., October 1, 2005; 73(10): 6363 - 6371.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. N. Wykes, Y.-H. Zhou, X. Q. Liu, and M. F. Good
Plasmodium yoelii Can Ablate Vaccine-Induced Long-Term Protection in Mice
J. Immunol., August 15, 2005; 175(4): 2510 - 2516.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
I.-K. YOON, E. ANGOV, D. LARSON, D. G. HEPPNER, J. F. CUMMINGS, and V. A. STEWART
CHARACTERIZATION OF A HUMAN REFERENCE STANDARD FOR ANTIBODY TO PLASMODIUM FALCIPARUM MEROZOITE SURFACE PROTEIN 142
Am J Trop Med Hyg, June 1, 2005; 72(6): 714 - 718.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. R. Elliott, R. D. Kuns, and M. F. Good
Heterologous Immunity in the Absence of Variant-Specific Antibodies after Exposure to Subpatent Infection with Blood-Stage Malaria
Infect. Immun., April 1, 2005; 73(4): 2478 - 2485.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. M. Burns Jr., P. R. Flaherty, P. Nanavati, and W. P. Weidanz
Protection against Plasmodium chabaudi Malaria Induced by Immunization with Apical Membrane Antigen 1 and Merozoite Surface Protein 1 in the Absence of Gamma Interferon or Interleukin-4
Infect. Immun., October 1, 2004; 72(10): 5605 - 5612.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. Sachdeva, G. Ahmad, P. Malhotra, P. Mukherjee, and V. S. Chauhan
Comparison of Immunogenicities of Recombinant Plasmodium vivax Merozoite Surface Protein 1 19- and 42-Kilodalton Fragments Expressed in Escherichia coli
Infect. Immun., October 1, 2004; 72(10): 5775 - 5782.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
L. Wang, M. W. Goschnick, and R. L. Coppel
Oral Immunization with a Combination of Plasmodium yoelii Merozoite Surface Proteins 1 and 4/5 Enhances Protection against Lethal Malaria Challenge
Infect. Immun., October 1, 2004; 72(10): 6172 - 6175.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
P. H. Corran, R. A. O'Donnell, J. Todd, C. Uthaipibull, A. A. Holder, B. S. Crabb, and E. M. Riley
The Fine Specificity, but Not the Invasion Inhibitory Activity, of 19-Kilodalton Merozoite Surface Protein 1-Specific Antibodies Is Associated with Resistance to Malarial Parasitemia in a Cross-Sectional Survey in The Gambia
Infect. Immun., October 1, 2004; 72(10): 6185 - 6189.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. R. Drew, R. A. O'Donnell, B. J. Smith, and B. S. Crabb
A Common Cross-species Function for the Double Epidermal Growth Factor-like Modules of the Highly Divergent Plasmodium Surface Proteins MSP-1 and MSP-8
J. Biol. Chem., May 7, 2004; 279(19): 20147 - 20153.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. I. Stanisic, L. B. Martin, M. L. Gatton, and M. F. Good
Inhibition of 19-kDa C-Terminal Region of Merozoite Surface Protein-1-Specific Antibody Responses in Neonatal Pups by Maternally Derived 19-kDa C-Terminal Region of Merozoite Surface Protein-1-Specific Antibodies but Not Whole Parasite-Specific Antibodies
J. Immunol., May 1, 2004; 172(9): 5570 - 5581.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
B. A. Okech, P. H. Corran, J. Todd, A. Joynson-Hicks, C. Uthaipibull, T. G. Egwang, A. A. Holder, and E. M. Riley
Fine Specificity of Serum Antibodies to Plasmodium falciparum Merozoite Surface Protein, PfMSP-119, Predicts Protection from Malaria Infection and High-Density Parasitemia
Infect. Immun., March 1, 2004; 72(3): 1557 - 1567.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. Kumar, T. R. Jones, M. S. Oakley, H. Zheng, S. P. Kuppusamy, A. Taye, A. M. Krieg, A. W. Stowers, D. C. Kaslow, and S. L. Hoffman
CpG Oligodeoxynucleotide and Montanide ISA 51 Adjuvant Combination Enhanced the Protective Efficacy of a Subunit Malaria Vaccine
Infect. Immun., February 1, 2004; 72(2): 949 - 957.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. Singh, M. C. Kennedy, C. A. Long, A. J. Saul, L. H. Miller, and A. W. Stowers
Biochemical and Immunological Characterization of Bacterially Expressed and Refolded Plasmodium falciparum 42-Kilodalton C-Terminal Merozoite Surface Protein 1
Infect. Immun., December 1, 2003; 71(12): 6766 - 6774.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. I. Stanisic, L. B. Martin, and M. F. Good
The Role of the 19-kDa Region of Merozoite Surface Protein 1 and Whole-Parasite-Specific Maternal Antibodies in Directing Neonatal Pups' Responses to Rodent Malaria Infection
J. Immunol., November 15, 2003; 171(10): 5461 - 5469.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
D. I. Stanisic, L. B. Martin, X. Q. Liu, D. Jackson, J. Cooper, and M. F. Good
Analysis of Immunological Nonresponsiveness to the 19-Kilodalton Fragment of Merozoite Surface Protein 1 of Plasmodium yoelii: Rescue by Chemical Conjugation to Diphtheria Toxoid (DT) and Enhancement of Immunogenicity by Prior DT Vaccination
Infect. Immun., October 1, 2003; 71(10): 5700 - 5713.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Yoshida, T. Kobayashi, H. Matsuoka, C. Seki, W. L. Gosnell, S. P. Chang, and A. Ishii
T-cell activation and cytokine production via a bispecific single-chain antibody fragment targeted to blood-stage malaria parasites
Blood, March 15, 2003; 101(6): 2300 - 2306.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
L. Kedzierski, C. G. Black, M. W. Goschnick, A. W. Stowers, and R. L. Coppel
Immunization with a Combination of Merozoite Surface Proteins 4/5 and 1 Enhances Protection against Lethal Challenge with Plasmodium yoelii
Infect. Immun., December 1, 2002; 70(12): 6606 - 6613.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. Wipasa, H. Xu, M. Makobongo, M. Gatton, A. Stowers, and M. F. Good
Nature and Specificity of the Required Protective Immune Response That Develops Postchallenge in Mice Vaccinated with the 19-Kilodalton Fragment of Plasmodium yoelii Merozoite Surface Protein 1
Infect. Immun., November 1, 2002; 70(11): 6013 - 6020.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Wipasa, C. Hirunpetcharat, Y. Mahakunkijcharoen, H. Xu, S. Elliott, and M. F. Good
Identification of T Cell Epitopes on the 33-kDa Fragment of Plasmodium yoelii Merozoite Surface Protein 1 and Their Antibody-Independent Protective Role in Immunity to Blood Stage Malaria
J. Immunol., July 15, 2002; 169(2): 944 - 951.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. A. Near, A. W. Stowers, D. Jankovic, and D. C. Kaslow
Improved Immunogenicity and Efficacy of the Recombinant 19-Kilodalton Merozoite Surface Protein 1 by the Addition of Oligodeoxynucleotide and Aluminum Hydroxide Gel in a Murine Malaria Vaccine Model
Infect. Immun., February 1, 2002; 70(2): 692 - 701.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
N. Ahlborg, I. T. Ling, W. Howard, A. A. Holder, and E. M. Riley
Protective Immune Responses to the 42-Kilodalton (kDa) Region of Plasmodium yoelii Merozoite Surface Protein 1 Are Induced by the C-Terminal 19-kDa Region but Not by the Adjacent 33-kDa Region
Infect. Immun., February 1, 2002; 70(2): 820 - 825.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Wipasa, H. Xu, A. Stowers, and M. F. Good
Apoptotic Deletion of Th Cells Specific for the 19-kDa Carboxyl-Terminal Fragment of Merozoite Surface Protein 1 During Malaria Infection
J. Immunol., October 1, 2001; 167(7): 3903 - 3909.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
R. A. O'Donnell, T. F. de Koning-Ward, R. A. Burt, M. Bockarie, J. C. Reeder, A. F. Cowman, and B. S. Crabb
Antibodies Against Merozoite Surface Protein (MSP)-119 Are a Major Component of the Invasion-inhibitory Response in Individuals Immune to Malaria
J. Exp. Med., June 18, 2001; 193(12): 1403 - 1412.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. J. Quin and J. Langhorne
Different Regions of the Malaria Merozoite Surface Protein 1 of Plasmodium chabaudi Elicit Distinct T-Cell and Antibody Isotype Responses
Infect. Immun., April 1, 2001; 69(4): 2245 - 2251.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. W. Stowers, V. Cioce, R. L. Shimp, M. Lawson, G. Hui, O. Muratova, D. C. Kaslow, R. Robinson, C. A. Long, and L. H. Miller
Efficacy of Two Alternate Vaccines Based on Plasmodium falciparum Merozoite Surface Protein 1 in an Aotus Challenge Trial
Infect. Immun., March 1, 2001; 69(3): 1536 - 1546.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. Chatterjee, S. Singh, R. Sohoni, N. J. Singh, A. Vaidya, C. Long, and S. Sharma
Antibodies against Ribosomal Phosphoprotein P0 of Plasmodium falciparum Protect Mice against Challenge with Plasmodium yoelii
Infect. Immun., July 1, 2000; 68(7): 4312 - 4318.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Xu, A. N. Hodder, H. Yan, P. E. Crewther, R. F. Anders, and M. F. Good
CD4+ T Cells Acting Independently of Antibody Contribute to Protective Immunity to Plasmodium chabaudi Infection After Apical Membrane Antigen 1 Immunization
J. Immunol., July 1, 2000; 165(1): 389 - 396.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
P. Vukovic, P. M. Hogarth, N. Barnes, D. C. Kaslow, and M. F. Good
Immunoglobulin G3 Antibodies Specific for the 19-Kilodalton Carboxyl-Terminal Fragment of Plasmodium yoelii Merozoite Surface Protein 1 Transfer Protection to Mice Deficient in Fc-gamma RI Receptors
Infect. Immun., May 1, 2000; 68(5): 3019 - 3022.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
N. Ahlborg, I. T. Ling, A. A. Holder, and E. M. Riley
Linkage of Exogenous T-cell Epitopes to the 19-Kilodalton Region of Plasmodium yoelii Merozoite Surface Protein 1 (MSP119) Can Enhance Protective Immunity against Malaria and Modulate the Immunoglobulin Subclass Response to MSP119
Infect. Immun., April 1, 2000; 68(4): 2102 - 2109.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. Kumar, W. Collins, A. Egan, A. Yadava, O. Garraud, M. J. Blackman, J. A. G. Patino, C. Diggs, and D. C. Kaslow
Immunogenicity and Efficacy in Aotus Monkeys of Four Recombinant Plasmodium falciparum Vaccines in Multiple Adjuvant Formulations Based on the 19-Kilodalton C Terminus of Merozoite Surface Protein 1
Infect. Immun., April 1, 2000; 68(4): 2215 - 2223.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Hirunpetcharat, P. Vukovic, X. Q. Liu, D. C. Kaslow, L. H. Miller, and M. F. Good
Absolute Requirement for an Active Immune Response Involving B Cells and Th Cells in Immunity to Plasmodium yoelii Passively Acquired with Antibodies to the 19-kDa Carboxyl-Terminal Fragment of Merozoite Surface Protein-1
J. Immunol., June 15, 1999; 162(12): 7309 - 7314.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
S. Matsumoto, H. Yukitake, H. Kanbara, and T. Yamada
Recombinant Mycobacterium bovis Bacillus Calmette-Guerin Secreting Merozoite Surface Protein 1 (MSP1) Induces Protection against Rodent Malaria Parasite Infection Depending on MSP1-stimulated Interferon gamma  and Parasite-specific Antibodies
J. Exp. Med., September 7, 1998; 188(5): 845 - 854.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. L. Rotman, T. M. Daly, R. Clynes, and C. A. Long
Fc Receptors Are Not Required for Antibody-Mediated Protection Against Lethal Malaria Challenge in a Mouse Model
J. Immunol., August 15, 1998; 161(4): 1908 - 1912.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
L. M. Spencer Valero, S. A. Ogun, S. L. Fleck, I. T. Ling, T. J. Scott-Finnigan, M. J. Blackman, and A. A. Holder
Passive Immunization with Antibodies against Three Distinct Epitopes on Plasmodium yoelii Merozoite Surface Protein 1 Suppresses Parasitemia
Infect. Immun., August 1, 1998; 66(8): 3925 - 3930.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
H. Xu, J. Wipasa, H. Yan, M. Zeng, M. O. Makobongo, F. D. Finkelman, A. Kelso, and M. F. Good
The Mechanism and Significance of Deletion of Parasite-specific CD4+ T Cells in Malaria Infection
J. Exp. Med., April 1, 2002; 195(7): 881 - 892.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.